EP 1206535 A1 20020522 - TUMOR-ASSOCIATED ANTIGEN (R11)
Title (en)
TUMOR-ASSOCIATED ANTIGEN (R11)
Title (de)
TUMORASSOZIIERTES ANTIGEN (R11)
Title (fr)
ANTIGENE (R11) SPECIFIQUE DE TUMEUR
Publication
Application
Priority
- DE 19936563 A 19990804
- EP 0007338 W 20000728
Abstract (en)
[origin: DE19936563A1] The invention relates to tumor-associated antigens, immunogenic peptides derived therefrom and the DNA molecules coding therefor as well as to their utilization in cancer immunotherapy.
IPC 1-7
IPC 8 full level
G01N 33/574 (2006.01); A61K 35/12 (2006.01); A61K 39/00 (2006.01); A61K 39/395 (2006.01); A61K 48/00 (2006.01); A61P 35/00 (2006.01); C07K 14/47 (2006.01); C07K 14/82 (2006.01); C07K 16/28 (2006.01); C07K 16/30 (2006.01); C07K 16/32 (2006.01); C12N 15/09 (2006.01); C12N 15/12 (2006.01); C12P 21/08 (2006.01); G01N 33/15 (2006.01); G01N 33/50 (2006.01); C12R 1/91 (2006.01)
CPC (source: EP)
A61P 35/00 (2018.01); C07K 14/4711 (2013.01); C07K 16/28 (2013.01); C07K 16/30 (2013.01); A61K 39/00 (2013.01); A61K 2039/505 (2013.01); A61K 2039/53 (2013.01)
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
DE 19936563 A1 20010208; AU 6278300 A 20010305; CA 2383230 A1 20010215; CO 5280153 A1 20030530; EP 1206535 A1 20020522; JP 2003506085 A 20030218; MX PA02001137 A 20021104; UY 26266 A1 20010131; WO 0111040 A1 20010215
DOCDB simple family (application)
DE 19936563 A 19990804; AU 6278300 A 20000728; CA 2383230 A 20000728; CO 00058185 A 20000802; EP 0007338 W 20000728; EP 00949421 A 20000728; JP 2001515826 A 20000728; MX PA02001137 A 20000728; UY 26266 A 20000802